in motion by the calcium transient (Kristian and Siesjo 1998) . For example, if NO' is produced when the oxygen supply is re-established, the simultaneous presence of NO, and reactive oxygen species, notably '0 2 -, can cre ate very harmful chemical species, such as hydroxyl radi cals (·OH) and peroxynitrite (Beckman et ai., 1990 , Sam dani et ai., 1997 .
In this paradigm of secondary damage, triggered by a nonphysiologic Ca2+ transient, the mitochondria occupy a central role. This is not only because mitochondrial dysfunction underlies the bioenergetic failure that trig gers the initial loss of cell calcium homeostasis, but also because the mitochondria absorb a major fraction of the cell calcium load once they become re-energized during recovery from an insult, or during reperfusion (Werth and Thayer 1994; White and Reynolds 1995; Schinder et aI. , 1996) . When doing so, they give a spurt of produc tion of reactive oxygen species (Dykens 1994; Dugan et al 1995; Reynolds and Hastings 1995; Piantadosi and Zhang 1996) . Furthermore, it is now widely assumed that metabolically strained mitochondria can release mol ecules that trigger a cascade of reactions leading to cell death, notably apoptosis.
In light of the re-emphasis of the pathogenetic role of mitochondria in brain disease, the article by Paschen and Doutheil (1999) seems almost heretical because the au thors put the ER, and the ER calcium homeostasis, into the focus of interest. Supported by extensive literature data, and by their own results, they argue, in a thoughtful and scientifically stringent manner, that the support of the mitochondrial origin of cell death is less than con clusive, and that much speaks in favor of an alternative, ER hypothesis. When addressing this apparent diver gence of opinions, in an area of clear relevance to human disease, we will briefly review the mitochondrial hypoth esis of (apoptotic) cell death, before discussing the evi dence supporting the role of the ER. However, it seems justified to begin by recalling some basic facts about cell calcium metabolism. Figure 1 gives a schematic overview of factors regu lating calcium homeostasis in internal stores, i. e. ER, calciosomes, and mitochondria. Cell calcium entry by voltage-sensiti ve and agonist-operated plasma mem brane channels leads to an increase in Ca2+j. Such an entry also leads to an increase in the total cell calcium content. Ca2+j also increases if the appropriate agonists (e.g. glutamate) activate surface receptors coupled to phospolipase C and when inositol trisphosphate (IP 3), formed during degradation of phosphatidyl inositol bis- Schematic diagram illustrating calcium fluxes associated with the endoplasmic reticulum (ER) and calciosomes (CC), as well as with mitochondria. The upper part of the figure shows that agonists (e.g. glutamate) acting on surface receptors coupled to phospholipase C (PLC) trigger the breakdown of phosphatidyl inositol bisphosphate (PIP 2 ) to inositol triphosphate (IP3) and dia cylglyceride (DG). Inositol trisphosphate activates surface recep tors on ER membranes, triggering Ca2+ release. The ensuing increase in Ca2+; can then activate ryanodine receptors on cal ciosomes, leading to further release of calcium. The ER and the calciosomes are reloaded with calcium by the sarcoplasmic endoplasmic reticulum Ca2+ -ATPase. These pumps are con nected to plasma membrane channels, yielding "capacitative" Ca2+ recharge of the internal stores. The lower part of the figure shows that Ca2+ uptake by the mitochondria occurs by an elec trophoretic uniporter, driven by LllJm' while efflux occurs by Ca2+J Na+ exchange, with WJNa+ exchange restoring the Na+ gradient. Under certain circumstances, a mitochondrial permeability tran sition (MPT) pore is assembled. This pore, which is blocked by cyclosporin A (CsA) would discharge any Ca2+ accumulated in the mitochondria.
CELL CALCIUM REGULATION
J Cereb Blood Flow Metab, Vol. 19, No.1, 1999 phosphate, activates IP3 receptors on the ER membranes. This is because IP3 receptor activation leads to release of Ca2+. The ensuing increase in Ca2+j (or, indeed, any in crease in Ca2+) can trigger release of additional calcium from ryanodine-and caffeine-sensitive stores in calcio somes, i.e. non-ER organelles that are insensitive to IP3. Additional intracellular calcium stores have been dis cussed, but these are neither sensitive to IP3 nor to rya nodine or caffeine, and their calcium content can only be discharged by the calcium ionophore A 23187 (Paschen and Dutheil 1999) .
Internal release of calcium causes an increase in Ca2+j but the only event increasing the total cell calcium con tent is influx through plasma membranes. However, Ca2+ efflux from ER and calciosomes triggers a compensatory influx of calcium by ATP-driven transport that is some how coupled to a corresponding calcium translocation across the plasma membrane. The transporter, i. e. the sarcoplasmic-endoplasmic reticulum Ca2+-ATPase, is in hibited by the plant alkaloid thapsigargin (T9).
At steady state, Ca2+j is determined by the balance between influx-efflux across the plasma membrane. In the somewhat shorter perspective, the balance between efflux and influx of calcium across the membranes of the ER and other internal stores plays a role in regulating Ca2+j• In an even shorter perspective, the mitochondria (and intracellular calcium buffering) plays an important role in dampening physiologic or pathologic transients.
As shown in the lower part of Fig. 1 , calcium is cycled across the inner mitochondrial membrane. Calcium cy cling across the membrane normally serves the purpose of regulating Ca2+ -dependent intramitochondrial dehy drogenases that control flux in the citric acid cycle, and of buffering large calcium loads during intense activation (Denton and McCormack, 1990; Gunter and Pfeiffer 1990; Nicholls, 1985; White and Reynolds 1995; Wang and Thayer 1996) . Ca2+ uptake by the mitochondria oc curs by a uniporter, driven by the mitochondrial mem brane potential (�/-1m)' The high capacity uniporter trans ports calcium at a rate that is proportional to Ca2+j; thus, if the latter increases to micromolar concentrations, large amounts of Ca2+ can accumulate in the mitochondria.
Efflux of Ca2+ from the mitochondria occurs by Ca2+j 2Na+ exchange, with coupled Na+jH+ exchange normal izing the Na+ gradient. This is a low-capacity system, suggesting that release of large calcium loads takes time. However, under certain circumstances, a mitochondrial permeability transition (MPT) pore is opened (" as sembled"), which is indiscriminately permeable to sol utes with a molecular mass of < 1500 d (Gunter and Pfeiffer 1990; Gunter et aI. , 1994; Zoratti and Szabo 1995; Bernardi and Petronilli 1996) . One result of the MPT pore opening is that any mitochondrial calcium load will be rapidly discharged.
MITOCHONDRIA AS TRIGGERS OF

CELL DEATH
It is debated whether the MPT has the physiologic function of releasing large mitochondrial calcium loads. What is known, though, is that an MPT pore assembly can lead to mitochondrial dysfunction and cell death (Zoratti and Szabo 1995; Schinder et al. , 1996; Zamzami et al., 1996 Zamzami et al., , 1997 Green and Reed 1998; Kroemer et al. , 1998; Mignotte and Vayssiere 1998) . The basic events during an MPT pore opening encompass equilibration of the electrochemical potential for H+ (� IL H +) thereby leading to a collapse of �lLm and to cessation of mito chondrial ATP formation (Fig. 2) . In fact, dissipation of � ILH + leads to a reversal of the Fo-F]-ATPase reaction, ATP being wasted in extruding H+. Mitochondrial per meability transition pore opening is inhibited by low in tramitochondrial pH, and by the immunosuppressant cy closporin A (CsA).
The adverse conditions leading to an MPT pore open ing encompass mitochondrial calcium accumulation and oxidative stress. In view of this, one intuitively feels that ischemia with recirculation sets the stage for MPT related pathology (Crompton and Andreeva 1993; Duchen et al. , 1993; Griffiths and Halestrap 1993; Rich ter 1993) . This assumption received strong support from the results of Uchino et al. , (1995 Uchino et al. , ( , 1998 , who showed that CsA, if allowed to pass the blood-brain barrier, vir tually eliminated the hippocampal CAl damage resulting from 7 or 10 minutes of forebrain ischemia in the rat. The results were further supported by those showing that CsA ameliorated the exaggerated ischemic brain damage in curred by hyperglycemic animals, and suppressed the postischemic seizures observed in these animals (Li et al. , 1997) . FK506, another immunosuppressant that lacks the ability of CsA to block the MPT pore assembly, had a less pronounced effect on CAl damage after forebrain ischemia (Drake et al. , 1996) . This suggests that the blocking of an MPT has neuroprotective effects over and above that caused by the immunosuppression.
We have already referred to the fact that the MPT, and perhaps mitochondrial dysfunction in general, constitute important triggers of cell death Zamzami et al. , 1997; Green and Reed 1998; Kroemer et ai., 1998) . The initial discussion of these events was centered on programmed cell death (apoptosis). How ever, it is now recognized that the triggers of cell death may be common to apoptosis and necrosis. Thus, a va riety of inducers can, dependent on the circumstances, trigger either the classical sequence of events leading to apoptosis or the equally established program causing ne crotic cell death (Hirsch et aI. , 1997; Green and Reed 1998; Kroemer et aI., 1998) . This concept is applicable also to cells of neuronal origin. In fact, some of the best evidence in support was derived from studies on neurons ability transition (MPT) pore is opened. Then, any W gradient created by respiratory activity will be dissipated and endogenous stores of ATP will be used to maintain the H+ gradient; even in the short perspective, though, the W gradient and the /liJm will de crease toward zero. GsA, cyclosporin A.
in primary culture, subjected to transient glutamate ex posures (Ankarcrona et aI. , 1995; Bonfoco et aI., 1995) . It turned out that brief exposures to moderate glutamate concentrations preferentially caused apoptotic cell death, whereas necrosis dominated after more dense and long lasting insults. Furthermore, the commitment to either apoptosis or necrosis correlated to the degree of mito chondrial dysfunction.
In discussing cellular events leading to mitochondria induced cell death, whether of the necrotic or apoptotic type, the following facts should be kept in mind (Mac Manus and Linnik, 1997; Wyllie, 1997; Green and Reed 1998; Thornberry and Lazebnik 1998) .
Much information on the cell death pathway has been obtained on the nematode cenorhabitis elegans in which death and survival genes have been identified.
The genes CED-3 and CED-4 promote apoptosis, whereas CED-9 inhibits apoptosis. CED-3 is a caspase, normally existing as a zymogen that can be activated by proteolytic self-cleavage. CED-4 binds to CED-3, promoting CED-3 activation. However, by binding to CED-4, CED-9 prevents it from activating CED-3.
The caspases comprise of a family of cysteine proteases which includes interleukin-l f3-converting enzyme (ICE, caspase 1), a protease involved in inflammation.
However, the mammalian homologue to CED-3 is caspase-3, the executioner of cell death. The homo logue to CED-4 is Apaf-l , and the homologues to CED-9 are anti-apoptotic members of the BCL-2 fam ily (Bcl-2, Bel-XL). This family also contains pro apoptotic members, such as BAX and BIC (Chao et aI. , 1995; White et aI. , 1998) .
Many of the proteins of the BCL-2 family are bound to the outer mitochondrial membrane. However, BCL-2 is also found on the cytoplasmic face of the plasma membrane, endoplasmic reticulum, and nuclear enve lope. This suggests that BCL-2 may "sense" the state and integrity of these membranes, possibly modulating their function by influencing the transmembrane flux of ions, and the release of protein molecules. Further more, since BAX is a cytosolic protein, it could influ ence any membrane facing the cytosol. Figure 3 , modified from Reed (1998, see also Zamzami et aI. , 1997; Kroemer et aI. , 1998) illus trates the cascade of mitochondria-triggered events that either leads to necrosis or to apoptosis. Cell death trig gers, such as mitochondrial calcium overload or oxida tive stress, can lead to mitochondrial depolarization and an MPT that, in turn, causes the mitochondria to swell. The depolarization and the swelling cause release of mi tochondrial proteins, including apoptosis-inducing factor and cytochrome c. If the decrease in L1f.Lm is sustained, the mitochondria remain depolarized and uncoupled, large amounts of reactive oxygen species are formed, and ATP production ceases. The end result is necrosis.
In a different setting, the mitochondrial depolarization is either reversible or cannot be observed; yet, cyto chrome c or other caspase inducers are released, possibly because the death triggers allow channels in the outer mitochondrial membrane to be opened for such release, e. g. by proapoptotic members of the BCL-2 family such as BAX. An MPT may or may not be involved; if it is, one can envisage a transient opening of the MPT pore. However, because the mitochondria maintain their com pact structure, the commitment to (apoptotic) cell death is the release of cytochrome c, apoptosis-inducing factor, or mitochondrial procaspases. Such proteins, when re leased, activate extramitochondrial caspases by binding to Apaf-l thereby forcing it to associate with procaspase-9, causing caspase-9 to be activated. Once this occurs, caspase-9 can cause other caspases (e. g. caspase-3) to be activated, leading to cell death.
This sequence of events is well established, but the participation of an MPT is largely unclarified. For ex ample, in some systems, caspase activation is known to feed back to the mitochondria, causing them to depolar ize. This means that mitochondrial failure may be the result of caspase activation and not its cause.
The sequence of events depicted in Fig. 3 demand additional explanation. We will recall some facts pertain ing to the initiation of the death signal and the activation of caspases which, as stated, are the executioners of cell death.
The death signal, committing cells to apoptotic death, can be cell injury or events occurring at surface recep tors. Injury to the cell may affect the mitochondria, as in disease conditions causing bioenergetic compro mise, but in other instances, the primarily affected structure may be the nucleus (e. g. radiation damage), or the plasma membrane (certain toxins). The death receptors belong to the TNF receptor gene family, the best-known being CD 95 (or Fas or Apo-l ). It is not immediately obvious that, in all these conditions, mi tochondrial dysfunction is what transmits the death signal to the executioners. As Fig. 3 shows, release of cytochrome c from mito chondria initiates cell death. Such release seems to provoke the assembly of an "apoptosome", which is composed of cytochrome c, Apaf-l , and procaspase 9. The result is activation of caspase 9 which then trig gers activation of other caspases, including caspase-3. Thus, once cytochrome c is released, the cell is com mitted to die by a rapid series of apoptotic events involving Apaf-l -mediated caspase activation (Kluck et aI. , 1997; Nicholson and Thornberry 1997; Reed 1997) . However, if large amounts of cytochrome c are released, the result may be necrotic cell death.
The release of cytochrome c is inhibited by the presence of BCL-2, possibly because BCL-2 (and Bel-X L ) can lessen the decrease in �J.Lm and prevent the MPT. By the same token, the pro-apoptotic Bax may induce apoptosis by enhancing the assembly of an MPT pore. However, an alternative possibility is that antiapop totic proteins (BCL-2 or Bel-X L )' docking at membrane sites, bind cofactors such as Apaf-l, thereby prevent ing them from activating procaspase-9, and that pro apoptotic members of the family (such as BAX or BIK) act by displacing the cofactors from their binding sites (Adams and Cory 1998) . The importance of the events illustrated in Fig. 3 
3. This schematic diagram, modified from Green and Reed (1998) , illustrates how mitochondria can trigger necrotic or apop totic cell death. We envisage that the "cell death trigger" is a decrease in Ll�m which is promoted by mitochondrial calcium accumulation or oxidative stress and counteracted by cyclosporin A (CsA) and the anti-apoptotic members of the BCL-2 gene fam ily. A sustained mitochondrial permeability transition (MPT) is apt to cause large amplitude mitochondrial swelling with outer mem brane rupture, leading to massive release of mitochondrial pro teins (and glutathione). The immediate result is collapse of the Ll�H +, uncoupling of phosphorylation, a spurt of production of reactive oxygen species (ROS) and cessation of ATP production, while the ultimate result is cell necrosis. The right-lower part of the figure shows that apoptotic cell death, spurted by release of cytochrome c and other apoptogenic factors, trigger cell death by a series of events which involve Apaf-1 and activation of caspases, including caspase-3 the "executioner" of cell death.
pore opening (Uchino et aI. , 1995; Li et aI. , 1997; Butcher et aI. , 1997) . Furthermore, release of cyto chrome c has been documented (Ouyang et aI. , 1998) , as has activation of caspase-3 (Hara et aI. , 1997; Chen et aI. , 1998) . Finally, caspase antagonists (e. g. z-VAD fmk) have been shown to ameliorate damage caused by forebrain (Chen et aI. , 1998) and focal (Endres et aI. , 1997; Hara et aI. , 1997) ischemia.
In summary, a variety of death triggers initiate a series of events that lead to apoptotic or necrotic cell death. The end result of the cascade of events thus triggered is ac tivation of caspase-3, the executioner of cell death. Al though caspase precursor are constitutively expressed in all living cells, inhibitors normally keep the affected pro teases inactive, and it takes a pro-apoptotic signal to activate initiator caspases, these in tum activating the effector caspases. The delicate balance between cell sur vival and cell death is significantly influenced by the pro-and anti-apoptotic influences exerted by members of the BCL-2 gene family. Extensive data suggest that, in upsetting the normal balance, the mitochondria and the MPT play a pivotal role.
THE ENDOPLASMIC RETICULUM AND
CELL DEATH
The compelling arguments put together by Paschen and Dutheil (1999) can be examined in light of the in formation contained in Figs. 1-3 . Two important facts should be recalled. First, release of Ca2+ from the ER compartments occurs in response to IP 3 (compartment 1) and to Ca2+ (compartment 2). Second, release from the first compartment is enhanced by IP3 agonists and blocked by IP3 antagonists, while release from compart ment 2, which houses the machinery for folding and processing of proteins, can be blocked by dantrolene.
Evidence in support of the endoplasmic reticulum hypothesis
As reviewed by Paschen and Dutheil (1999) the fol lowing facts can be quoted in support of the ER hypoth esis of cell death.
In vivo results such as those obtained after transient isch emia show that, in all brain areas affected by the insult, overall protein synthesis rate is depressed. In some ischemia-resistant areas, this depression is transient, but in others, notably the vulnerable ones, it is sus tained. At first sight, this could result from the influx release of Ca2+, increasing Ca2+j to intolerable levels. However, Paschen and Dutheil (1999) argue that this is not the problem, particularly since, at least in vitro, protein synthesis is depressed even if Ca2+ is pre vented from increasing by Ca2+ chelators. This leads to the conclusion that it is the decrease in Ca2+ ER that leads to inhibition of protein synthesis. In spite of these results, it can be discussed if the depres sion of protein synthesis is the cause of the ultimate cell death, or if it is an epiphenomenon. Paschen and Dutheil (1999) submit that the latter may be the case, and argue that the cause of cell death is a dysfunction of ER membranes, reflecting an imbalance between passive efflux of calcium and energy-dependent re entry. Also, ER dilatation is observed in ischemia, obviously preceding necrotic cell death. The authors dismiss the mitochondrial hypothesis on several grounds. The first one is that CsA, the virtually specific blocker of the MPT pore discussed above, also affects cell ER metabolism and function. For ex ample, CsA is known to induce expression of the ER resident stress protein grp78, which is an established neuroprotectant. Furthermore, CsA was reported to block TG-induced apoptosis in a setting where A TP concentrations were normal. Finally, additional results suggest the CsA directly modulates the ER calcium pump activity in extracerebral systems in vitro. As a final argument, it was emphasized that, in vivo, both
CsA and the immunosuppressant FK506. have proven anti-ischemic effects, although FK506 does not block the MPT pore.
Additional arguments derive from the fact that, in vitro, TG, an irreversible blocker of the ER Ca2+-ATPase, can induce a block of cell division, growth arrest of cells, and apoptosis. TG-induced apoptosis is accom panied by activation of caspase-3 and suppressed by caspase inhibitors such as Z-VAD-fmk. Furthermore, dantrolene, which blocks Ca2+ release through the ER ryanodine receptor channel, is neuroprotective in vivo. Another argument is that BCL-2 and its protein products are found also in ER membranes. Results have shown that they are able to suppress the depletion of ER calcium stores in several pathologic states, suggesting that this anti-apoptotic gene and its protein products modulate Ca2+ flux between the cytosol and the ER, or between different ER compartments.
The final arguments are based on in vivo experiments on animals subjected to ischemic transients. In these, an tagonists of metabotropic glutamate receptors proved to be neuroprotective, whereas IP-3 receptor agonists aggravate tissue damage. It is also of interest that IP3 receptor agonists, when injected intracerebroventricu larly, induce seizures and brain damage.
Reservations
In spite of these compelling arguments it cannot be accepted without reservations that the ER is a primary trigger of cell death. We wish to raise the following points.
Admittedly, the immunosuppressant CsA does not act J Cereb Blood Flow Metab, Vol. 19, No.1, 1999 exclusively on mitochondrial membranes. Like FK506, it suppresses calcineurin, a phosphatase in volved in NO metabolism; furthermore, both immu nosuppressants antagonize rotamase activity, i.e. they act to suppress leucine cis-trans isomerase activity, required for protein folding (e.g. Steiner et aI. , 1997) . What is unique to CsA is that it blocks the MPT pore. FK506 does not do that. However, it has been reported that FK506 blocks an unspecific large conductance channel in ER membranes. This could explain why both CsA and FK506 "stabilize" membranes whose integrity is essential for cell survival. However, it does not identify the ER as a trigger of apoptotic cell death.
As stated, BCL-2 is not exclusively localized to mito chondrial membranes but is also found on the cytoso lic side of ER plasma and nuclear membranes. This suggests that anti-apoptotic members of the BCL-2 family act to stabilize membranes, e. g. by protecting them from free radical attack (Kane et aI. , 1993) , and to prevent release of apoptogenic factors to the cytosol and activation of cytosolic caspases. Again, this does not prove that ER membrane dysfunction is a leading event in the triggering of apoptosis, to the exclusion of mitochondria. Thus, although the apoptosis-inducing effect of TG is suggestive, it has not been established that ER dysfunction, and the signals this may create, precedes mitochondrial dysfunction and release of mi tochondria-derived apoptogenic factors. At best, the results suggest that ER dysfunction contributes to cell death.
Compelling evidence suggesting a mitochondrial origin of necrotic and apoptotic cell death is that necrosis seems to require failure of mitochondrial ATP produc tion and apoptotic release of mitochondrial factors, such as cytochrome c, apoptosis-inducing factor, and procaspases. That these are of mitochondrial origin is shown by the fact that mitochondria, when subjected to depolarizing conditions, can induce all the morpho logic signs of apoptosis in isolated nuclei. Conceiv ably, similar factors can be released from metaboli cally perturbed ER membranes, but this has not yet been shown. Other evidence, equally compelling, show that when neurons in vitro are subjected to glutamate transients, they are protected by drugs that inhibit calcium uptake by the mitochondria (Stout, 1998) . Because these drugs do not inhibit calcium influx into cells, or the increase in Ca2+i levels, the results suggest that mito chondrial calcium uptake is of decisive pathogenetic importance.
In summary, the evidence discussed by Paschen and Dutheil (1999) question the overriding importance of mi tochondria in triggering apoptosis-necrosis and puts the ER calcium metabolism, and the ER membranes, into the focus. Clearly, they can lean on the facts that TO, which has no known effects on the mitochondria. can induce apoptosis, and that BCL-2 resides on the cytoplasmic face of ER membranes, obviously influencing ER mem brane function. Further support for their hypothesis is that ischemic cell death is ameliorated by IP 3 antagonists and by dantrolene, a known blocker of ryanodine recep tors. However, although these results suggest that ER dysfunction contributes to brain damage after ischemic transient, they do not invalidate the mitochondrial hy pothesis of necrotic-apoptotic cell death. It seems highly justified that additional information is obtained on this SUbject, particularly on any proapoptotic factors released from the ER.
